Good MorningThe S&P 500 gained more than 0.50% on Monday to put the index on track for its best month since April. The broad market index is up roughly 10% in that time and poised for more gains in the coming month. The final month of the year will bring the busiest shopping period of the year and could drive the market to new highs. The latest NRF estimates have holiday spending up 5.2% in 2020.
Investors need to be cautious this week. With the holiday season upon us market volume will be light and market moves may not reflect reality. This week is light on earnings but chock full of economic releases to drive the market. Along with that are rising numbers of COVID cases and the risk of another economic shutdown. The post-holiday season could be telling, with all the expected traffic the darkest days of COVID may still be ahead.
Featured: The Calm Before the Rotation — What’s Quietly Building Now (Stock Wire News) (Ad) 
|
Communication Services | | It’s been an eventful November for Roku (NASDAQ: ROKU). On November 6, shares climbed 12.6% to all-time highs after the streaming company reported Q3 earnings.
The very next trading session was November 9 – the day the Pfizer (NYSE: PFE) vaccine news came out. Investors feared that Roku... Read the Full Story |
|
From Our Partners | | One fund holds Nvidia, CrowdStrike, Palantir and other major AI names, and pays a 34% annualized distribution rate.
Instead of guessing which AI stock wins, this fund delivers income every single Thursday, up to $1,051 a month.
Chief Income Strategist Tim Plaehn breaks down what's inside the fund and how the weekly payouts work. | | Watch the free video to see how the weekly payouts work |
|
Technology | | Back at the start of 2020, few on Wall Street could have imagined that shares of Canadian e-commerce giant Shopify (NYSE: SHOP) would be trading above $1,000 by the time Q4 rolled around. To be sure, they were on an upward trajectory that made the eventuality almost a certainty but having only poppe... Read the Full Story |
|
Consumer Staples | |
With Black Friday coming up next week, now might be the perfect time to do some shopping for your investment portfolio. It’s sure to be one of the busiest spending days of the year, as in 2019 online shopping sales hit an all-time high of $7.4 billion. Every year, more and more companies are... Read the Full Story |
|
From Our Partners | | More than 25 candidates were screened for share price between $1 and $5, market cap above $100 million, daily volume over 500,000 shares, and over $10 million in trailing revenue.
Only five stocks cleared every filter, spanning five different sectors. Two are profitable today, and one pays a substantial dividend.
The report also flags what could go wrong with each pick, including dilution and convertible debt. | | See the five stocks that survived this strict revenue screen |
|
Markets | | Banking as a service company Green Dot Corporation (NASDAQ: GDOT) has transformed itself from just a prepaid debit card maker to a fully integrated fintech bank holding company in a few years. Shares are still outperforming the benchmark S&P 500 index (NYSEARCA: SPY). The growth of mainstream di... Read the Full Story |
|
Consumer Discretionary | | Williams-Sonoma Is A Proven Winner
Williams-Sonoma (NYSE:WSM) emerged as a pandemic-winner over the summer and what I can say now is that trends are accelerating. The combination of brand and eCommerce is a winning combination that is driving not only high-double-digit sales growth but accelerating... Read the Full Story |
|
From Our Partners | | Tobacco, telecom, pipelines, and healthcare real estate trade at 10 to 15 times earnings while the index yields about 1 percent.
A free report highlights seven cash-generating stocks with a 5 percent forward yield floor and roughly 6.5 percent average cash yield, capped at two picks per sector.
Each pick includes coverage numbers and an honest bear case. Five of the seven have raised payouts for 17 to 56 straight years. | | Get the seven high-yield dividend stocks free now |
|
Consumer Discretionary | | Since the onset of the pandemic:
Fewer people are going out for breakfast.
The work-at-home shift has turned many offices into ghost towns.
Business travel is a fraction of what it once was.
All resulting in… Fewer cups of coffee being purchased.
That Starbucks (NASDAQ: SBUX) struggl... Read the Full Story |
|
Consumer Staples | |
This year has dramatically changed the consumer shopping landscape. The pandemic has altered the way we buy both essential and non-essential goods and accelerated e-commerce growth globally.
So, it stands to reason that certain consumer-related stocks should continue to benefit from the unusual s... Read the Full Story |
|
Consumer Discretionary | | Electric vehicle (EV) company Kandi Technologies Group, Inc. (NASDAQ: KNDI) stock has seen interest in recent months as the EV craze pivoted from Tesla (NASDAQ: TSLA) to Chinese EV makers. With the recent earnings blowout momentum from Chinese EV makers like Xpeng (NYSE: XPEV) and Li Auto (NYSE: LI)... Read the Full Story |
|
Consumer Staples | | Target Is A Clear Winner
Target (NYSE:TGT) has long been a favorite of mine. The stock has gained more than 100% since I first called it a buy and there are more gains still to come. Strictly speaking from the perspective of value, the stock is trading about 22X this year’s earnings and in-li... Read the Full Story |
|
Healthcare | |
The good news about this whole COVID-19 mess, if anything about it can be said to be good news, is that it has focused science to a degree probably not thought possible on several fronts. Vaccine development has taken off like a skyrocket, and now, we have several candidates well on their way thro... Read the Full Story |
|
The Early Bird Stock Of The Day Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada. | | View Today's Stock Pick |
|